Strongly Increased International Normalized Ratio with Recombinant Neoplastin R® Compared with Tissue Extract Neoplastin Plus® in Patients Initiating Oral Anticoagulant Therapy: Implications for Anticoagulation Dosage-Reference-Cited by-同舟云学术

Strongly Increased International Normalized Ratio with Recombinant Neoplastin R® Compared with Tissue Extract Neoplastin Plus® in Patients Initiating Oral Anticoagulant Therapy: Implications for Anticoagulation Dosage

Published:2008-11-01 Issue:11 Volume:54 Page:1929-1931
ISSN:0009-9147
Container-title:Clinical Chemistry
language:en
Short-container-title:

Author:

Remijn Jasper A,Lucas Sam¹,Wildeboer Bertil¹,van Suijlen Jeroen D E¹,Adriaansen Henk J¹

Affiliation:

1. Department of Clinical Chemistry and Laboratory Hematology, Gelre ziekenhuizen, Apeldoorn/Zutphen, the Netherlands

Publisher

Oxford University Press (OUP)

Subject

Biochemistry, medical,Clinical Biochemistry

Link

http://academic.oup.com/clinchem/article-pdf/54/11/1929/32673406/clinchem1929.pdf

Reference5 articles.

1. Multicentric Evaluation of a New PT Reagent Based on Recombinant Human Tissue Factor and Synthetic Phospholipids

2. Comparison of plasma prothrombin and factor VII and urine prothrombin F1 concentrations in patients on long-term warfarin therapy and those in the initial phase

3. Reliability of the international normalized ratio for monitoring the induction phase of warfarin: Comparison with the prothrombin time ratio

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of warfarin overdose and related factors in the emergency department;The European Research Journal;2024-09-04

2. Interference of lupus anticoagulant causing antiprothrombin and anti–beta-2-glycoprotein I antibodies on international normalized ratio measurements: comparative analysis of international normalized ratio methods;Research and Practice in Thrombosis and Haemostasis;2024-07

3. Effect of anticoagulant adjustment on prothrombin time test using two different PT reagents in patients with elevated hematocrit;Practical Laboratory Medicine;2020-11

4. Monitoring of treatment with vitamin K antagonists: recombinant thromboplastins are more sensitive to factor VII than tissue-extract thromboplastins;Journal of Thrombosis and Haemostasis;2017-02-15

5. Monitoring anticoagulant therapy with vitamin K antagonists in patients with antiphospholipid syndrome;Annals of Hematology;2015-04-10